Purpose We conducted two World Health Organization-commissioned reviews to inform use
of high-flow nasal cannula (HFNC) in patients with coronavirus disease (COVID-19). We …

Infection with the novel 2019 coronavirus (SARS-CoV-2) is associated with the development
of a viral pneumonia with severe hypoxemia and respiratory failure. In many cases these …

During the coronavirus disease 2019 (COVID-19) pandemic, noninvasive respiratory
support has played a central role in managing patients affected by moderate-to-severe acute …

Human-to-human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
transmission has been established, with> 3300 clinicians reported to be infected in China …

In recent years, high flow nasal cannula (HFNC) is a respiratory support system that has
become prominent in the treatment of respiratory failure. HFNC provides higher …

High-flow nasal cannula (HFNC) has been shown to improve oxygenation and reduce the
need for intubation for hypoxaemic patients [1]. A retrospective study reported the …

Background It had been shown that High-flow nasal cannula (HFNC) is an effective initial
support strategy for patients with acute respiratory failure. However, the efficacy of HFNC for …

The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …

Hypoxemic respiratory failure is a common manifestation of COVID-19 pneumonia. Early in
the COVID-19 pandemic, patients with hypoxemic respiratory failure were, at times, being …

Methods A retrospective, observational study was performed at a single centre, evaluating
patients with ARDS secondary to COVID-19 treated with HFNC. The main outcome was the …